methylene blue has been researched along with B16 Melanoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correia, NA; Crugeira, PJL; Fagnani, SR; Monteiro, JCS; Oliveira, SCPS; Pinheiro, ALB; Sampaio, FP; Santos, GMP | 1 |
| Chen, Y; Ji, J; Li, Y; Shen, P; Zheng, W; Zhong, J | 1 |
| Gama, MF; Machado Filho, CD; Paschoal, FM; Pinhal, MA; Suarez, ER; Tardivo, JP; Theodoro, TR; Wagner, M | 1 |
| Andrade, SP; Hart, IR; Piper, PJ | 1 |
| Brown, I; Carpenter, RN; Link, EM; Mitchell, JS | 1 |
5 other study(ies) available for methylene blue and B16 Melanoma
| Article | Year |
|---|---|
ROS-induced autophagy reduces B16F10 melanoma cell proliferative activity.
Topics: Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Fluorescence; Humans; Lasers; Melanoma, Experimental; Methylene Blue; Mice; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2018 |
Apoptosis induced by methylene-blue-mediated photodynamic therapy in melanomas and the involvement of mitochondrial dysfunction revealed by proteomics.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Immunohistochemistry; Melanoma, Experimental; Membrane Potential, Mitochondrial; Methylene Blue; Mice; Mitochondria; Models, Biological; Photochemotherapy; Photosensitizing Agents; Proteomics | 2008 |
Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases.
Topics: Animals; Biomarkers, Tumor; Disease Models, Animal; Enzyme Inhibitors; Female; Glucuronidase; Immunohistochemistry; Melanoma, Experimental; Methylene Blue; Mice; Mice, Nude; Photochemotherapy; Photosensitizing Agents; Proliferating Cell Nuclear Antigen; Skin Neoplasms | 2012 |
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Colonic Neoplasms; Male; Melanoma, Experimental; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostheses and Implants; Regional Blood Flow | 1992 |
Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.
Topics: Animals; Astatine; Drug Carriers; Iodine Radioisotopes; Melanoma, Experimental; Methylene Blue; Mice; Mice, Inbred C57BL; Tissue Distribution; Tumor Cells, Cultured | 1989 |